ARCHIVES

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?

June 30, 2000

PLCO Data Confirm Importance Of Regular Colorectal Cancer Screening, NCI Says

July 25, 2003

Hybridoma Cell Lines Available from NCI

September 3, 1982

Time-Out For A New Sense Of Cooperation, Urgency.

January 21, 2000

Research: No Increase in Cancer Deaths Found at Three Mile Island

May 5, 2000

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

October 23, 1992